Skip to main content

Roberto Orsenigo

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Roberto Orsenigo

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Tumor dependent immune evasive mechanisms in melanoma

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Eva Muñoz Couselo, Yuxin Ding, Roberto Orsenigo
Funding agency: Instituto de Salud Carlos III
Funding: 321250
Reference: PI23/00428
Duration: 01/01/2024 - 31/12/2026

Discovering intratumoral immune-cell resistance mechanisms to immunotherapy response

IP: Juan Angel Recio Conde
Collaborators: Roberto Orsenigo
Funding agency: Fundació "La Caixa"
Funding: 115092
Reference: CAIXA/INPHINIT/2022/ORSENIGO
Duration: 01/11/2022 - 31/10/2025

Related news

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

Related professionals

David Hernandez Morales

David Hernandez Morales

Research technician
Stroke research
Read more
Marta González Sepúlveda

Marta González Sepúlveda

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Olga Simó Servat

Olga Simó Servat

Main researcher
Diabetes and Metabolism
Read more
Zoraida Alvarez Diaz

Zoraida Alvarez Diaz

Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.